DORMAN PRODUCTS INC (DORM) Fundamental Analysis & Valuation

NASDAQ:DORM • US2582781009

105.66 USD
-1.23 (-1.15%)
At close: Mar 11, 2026
105.66 USD
0 (0%)
After Hours: 3/11/2026, 5:20:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This DORM fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Taking everything into account, DORM scores 6 out of 10 in our fundamental rating. DORM was compared to 41 industry peers in the Automobile Components industry. While DORM has a great profitability rating, there are some minor concerns on its financial health. DORM is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

9

1. DORM Profitability Analysis

1.1 Basic Checks

  • DORM had positive earnings in the past year.
  • In the past year DORM had a positive cash flow from operations.
  • Of the past 5 years DORM 4 years were profitable.
  • Of the past 5 years DORM 4 years had a positive operating cash flow.
DORM Yearly Net Income VS EBIT VS OCF VS FCFDORM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

  • DORM's Return On Assets of 9.70% is amongst the best of the industry. DORM outperforms 90.24% of its industry peers.
  • The Return On Equity of DORM (16.70%) is better than 92.68% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 13.16%, DORM belongs to the top of the industry, outperforming 90.24% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for DORM is in line with the industry average of 9.20%.
  • The last Return On Invested Capital (13.16%) for DORM is above the 3 year average (9.34%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.7%
ROE 16.7%
ROIC 13.16%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
DORM Yearly ROA, ROE, ROICDORM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • The Profit Margin of DORM (11.65%) is better than 97.56% of its industry peers.
  • In the last couple of years the Profit Margin of DORM has grown nicely.
  • With an excellent Operating Margin value of 16.71%, DORM belongs to the best of the industry, outperforming 97.56% of the companies in the same industry.
  • In the last couple of years the Operating Margin of DORM has grown nicely.
  • DORM's Gross Margin of 41.88% is amongst the best of the industry. DORM outperforms 87.80% of its industry peers.
  • DORM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.71%
PM (TTM) 11.65%
GM 41.88%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
DORM Yearly Profit, Operating, Gross MarginsDORM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. DORM Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DORM is creating some value.
  • There is no outstanding debt for DORM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DORM Yearly Shares OutstandingDORM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DORM Yearly Total Debt VS Total AssetsDORM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • DORM has an Altman-Z score of 4.32. This indicates that DORM is financially healthy and has little risk of bankruptcy at the moment.
  • DORM has a better Altman-Z score (4.32) than 82.93% of its industry peers.
  • The Debt to FCF ratio of DORM is 4.33, which is a neutral value as it means it would take DORM, 4.33 years of fcf income to pay off all of its debts.
  • DORM has a better Debt to FCF ratio (4.33) than 73.17% of its industry peers.
  • DORM has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
  • DORM has a Debt to Equity ratio of 0.28. This is in the better half of the industry: DORM outperforms 63.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 4.33
Altman-Z 4.32
ROIC/WACC1.43
WACC9.22%
DORM Yearly LT Debt VS Equity VS FCFDORM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 2.94 indicates that DORM has no problem at all paying its short term obligations.
  • DORM has a Current ratio of 2.94. This is in the better half of the industry: DORM outperforms 73.17% of its industry peers.
  • DORM has a Quick Ratio of 1.19. This is a normal value and indicates that DORM is financially healthy and should not expect problems in meeting its short term obligations.
  • DORM's Quick ratio of 1.19 is in line compared to the rest of the industry. DORM outperforms 43.90% of its industry peers.
Industry RankSector Rank
Current Ratio 2.94
Quick Ratio 1.19
DORM Yearly Current Assets VS Current LiabilitesDORM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. DORM Growth Analysis

3.1 Past

  • DORM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.23%, which is quite impressive.
  • Measured over the past years, DORM shows a very strong growth in Earnings Per Share. The EPS has been growing by 20.72% on average per year.
EPS 1Y (TTM)24.23%
EPS 3Y23.06%
EPS 5Y20.72%
EPS Q2Q%-1.36%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.78%

3.2 Future

  • Based on estimates for the next years, DORM will show a small growth in Earnings Per Share. The EPS will grow by 6.46% on average per year.
  • The Revenue is expected to grow by 5.64% on average over the next years.
EPS Next Y0.95%
EPS Next 2Y5.42%
EPS Next 3Y-0.14%
EPS Next 5Y6.46%
Revenue Next Year5.43%
Revenue Next 2Y5.1%
Revenue Next 3Y5.65%
Revenue Next 5Y5.64%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DORM Yearly Revenue VS EstimatesDORM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
DORM Yearly EPS VS EstimatesDORM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. DORM Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 11.91 indicates a reasonable valuation of DORM.
  • Based on the Price/Earnings ratio, DORM is valued a bit cheaper than 65.85% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.25, DORM is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 11.80, the valuation of DORM can be described as very reasonable.
  • DORM's Price/Forward Earnings ratio is in line with the industry average.
  • When comparing the Price/Forward Earnings ratio of DORM to the average of the S&P500 Index (24.39), we can say DORM is valued rather cheaply.
Industry RankSector Rank
PE 11.91
Fwd PE 11.8
DORM Price Earnings VS Forward Price EarningsDORM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • DORM's Enterprise Value to EBITDA is on the same level as the industry average.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as DORM.
Industry RankSector Rank
P/FCF 30.32
EV/EBITDA 8.82
DORM Per share dataDORM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DORM does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of DORM may justify a higher PE ratio.
PEG (NY)12.59
PEG (5Y)0.57
EPS Next 2Y5.42%
EPS Next 3Y-0.14%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DORM Dividend Analysis

5.1 Amount

  • DORM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DORM Fundamentals: All Metrics, Ratios and Statistics

DORMAN PRODUCTS INC

NASDAQ:DORM (3/11/2026, 5:20:01 PM)

After market: 105.66 0 (0%)

105.66

-1.23 (-1.15%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)02-25
Earnings (Next)05-04
Inst Owners89.57%
Inst Owner Change0.85%
Ins Owners13.14%
Ins Owner Change2.81%
Market Cap3.19B
Revenue(TTM)N/A
Net Income(TTM)247.63M
Analysts82.86
Price Target173.78 (64.47%)
Short Float %4.2%
Short Ratio5.5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.25%
Min EPS beat(2)2.92%
Max EPS beat(2)11.58%
EPS beat(4)4
Avg EPS beat(4)15.07%
Min EPS beat(4)2.92%
Max EPS beat(4)36.11%
EPS beat(8)8
Avg EPS beat(8)23.63%
EPS beat(12)8
Avg EPS beat(12)10.09%
EPS beat(16)9
Avg EPS beat(16)7.08%
Revenue beat(2)1
Avg Revenue beat(2)-0.17%
Min Revenue beat(2)-3.26%
Max Revenue beat(2)2.92%
Revenue beat(4)2
Avg Revenue beat(4)0.68%
Min Revenue beat(4)-3.26%
Max Revenue beat(4)3.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.93%
Revenue beat(12)3
Avg Revenue beat(12)-0.87%
Revenue beat(16)6
Avg Revenue beat(16)0.21%
PT rev (1m)0%
PT rev (3m)-1.8%
EPS NQ rev (1m)0.06%
EPS NQ rev (3m)0%
EPS NY rev (1m)0.04%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 11.91
Fwd PE 11.8
P/S 1.5
P/FCF 30.32
P/OCF 22.3
P/B 2.15
P/tB 4.11
EV/EBITDA 8.82
EPS(TTM)8.87
EY8.39%
EPS(NY)8.95
Fwd EY8.47%
FCF(TTM)3.48
FCFY3.3%
OCF(TTM)4.74
OCFY4.48%
SpS70.45
BVpS49.12
TBVpS25.73
PEG (NY)12.59
PEG (5Y)0.57
Graham Number99.02
Profitability
Industry RankSector Rank
ROA 9.7%
ROE 16.7%
ROCE 17.45%
ROIC 13.16%
ROICexc 13.53%
ROICexgc 21.03%
OM 16.71%
PM (TTM) 11.65%
GM 41.88%
FCFM 4.95%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
ROICexc(3y)9.58%
ROICexc(5y)10.64%
ROICexgc(3y)16.14%
ROICexgc(5y)16.08%
ROCE(3y)13.07%
ROCE(5y)14.22%
ROICexgc growth 3Y8.15%
ROICexgc growth 5Y10.63%
ROICexc growth 3Y3.74%
ROICexc growth 5Y2.76%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
F-Score7
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 4.33
Debt/EBITDA 1.02
Cap/Depr 67.78%
Cap/Sales 1.78%
Interest Coverage 11.7
Cash Conversion 34.78%
Profit Quality 42.47%
Current Ratio 2.94
Quick Ratio 1.19
Altman-Z 4.32
F-Score7
WACC9.22%
ROIC/WACC1.43
Cap/Depr(3y)78.22%
Cap/Depr(5y)67.78%
Cap/Sales(3y)2.14%
Cap/Sales(5y)1.86%
Profit Quality(3y)77.16%
Profit Quality(5y)84.08%
High Growth Momentum
Growth
EPS 1Y (TTM)24.23%
EPS 3Y23.06%
EPS 5Y20.72%
EPS Q2Q%-1.36%
EPS Next Y0.95%
EPS Next 2Y5.42%
EPS Next 3Y-0.14%
EPS Next 5Y6.46%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.78%
Revenue Next Year5.43%
Revenue Next 2Y5.1%
Revenue Next 3Y5.65%
Revenue Next 5Y5.64%
EBIT growth 1Y25.27%
EBIT growth 3Y19.51%
EBIT growth 5Y22.59%
EBIT Next Year38.49%
EBIT Next 3Y14.14%
EBIT Next 5YN/A
FCF growth 1Y-8.15%
FCF growth 3Y33.52%
FCF growth 5Y23.87%
OCF growth 1Y-11.46%
OCF growth 3Y32.07%
OCF growth 5Y19.38%

DORMAN PRODUCTS INC / DORM FAQ

What is the ChartMill fundamental rating of DORMAN PRODUCTS INC (DORM) stock?

ChartMill assigns a fundamental rating of 6 / 10 to DORM.


Can you provide the valuation status for DORMAN PRODUCTS INC?

ChartMill assigns a valuation rating of 5 / 10 to DORMAN PRODUCTS INC (DORM). This can be considered as Fairly Valued.


What is the profitability of DORM stock?

DORMAN PRODUCTS INC (DORM) has a profitability rating of 9 / 10.


Can you provide the financial health for DORM stock?

The financial health rating of DORMAN PRODUCTS INC (DORM) is 6 / 10.


How sustainable is the dividend of DORMAN PRODUCTS INC (DORM) stock?

The dividend rating of DORMAN PRODUCTS INC (DORM) is 0 / 10 and the dividend payout ratio is 0%.